PrednisolonePrednisoneGlucocorticoidsVincristineAnti-Inflammatory AgentsAzathioprineCyclophosphamideImmunosuppressive AgentsDrug Therapy, CombinationMethylprednisoloneDoxorubicinAntineoplastic Combined Chemotherapy ProtocolsProcarbazineTreatment OutcomeMechlorethamineAdministration, OralDrug Administration ScheduleCyclosporinePulse Therapy, DrugMelphalanAntibodies, Monoclonal, Murine-DerivedChlorambucilRemission InductionBell PalsyMethotrexateNephrotic SyndromeAdrenal Cortex HormonesMitoxantroneDouble-Blind MethodPolymyalgia RheumaticaMycophenolic AcidBleomycinKidney TransplantationTime FactorsFollow-Up StudiesHydrocortisoneAsparaginaseLymphoma, Non-HodgkinRecurrenceColor TherapyHodgkin DiseaseArthritis, RheumatoidLymphoma, Large B-Cell, DiffuseDose-Response Relationship, DrugDexamethasoneVinblastineTacrolimusClinical Trials as TopicAntirheumatic AgentsGraft RejectionThalidomide6-MercaptopurineTablets, Enteric-CoatedMultiple MyelomaPregnenedionesEtoposideCombined Modality TherapySurvival AnalysisLupus Erythematosus, SystemicCyclosporinsBeclomethasoneProspective StudiesRemission, SpontaneousPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatitis, AutoimmuneAsthmaRetrospective StudiesDisease-Free SurvivalBetamethasoneSurvival RateMyasthenia GravisVindesineEnemaIsonipecotic AcidsEosinophiliaImmunosuppressionGiant Cell ArteritisSarcoidosisHydroxychloroquineBudesonideSulfasalazineAntineoplastic Agents, HormonalPrognosisColitis, UlcerativeLymphoma, FollicularSeverity of Illness IndexTriamcinolonePlasmapheresisTaxoidsInjections, IntravenousLeukocyte CountDermatomyositisDog DiseasesBiopsy11-HydroxycorticosteroidsThrombocytopeniaAcute DiseaseGraft SurvivalDaunorubicinAntilymphocyte Serum